Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design Running title: Reasons for phase III failure in HCC

Abstract

1 HCC Translational Research Laboratory, Barcelona-Clínic Liver Cancer Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Universitat de Barcelona (UB), Barcelona, Catalonia, Spain. 2 Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Ichan School of Medicine at Mount Sinai, New York, New York, USA. 3 Institució Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain

2 Figures and Tables

Cite this paper

@inproceedings{Llovet2014HepatocellularCR, title={Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design Running title: Reasons for phase III failure in HCC}, author={Josep Mar{\'i}a Llovet and Virginia Hern{\'a}ndez-Gea}, year={2014} }